Furudate Sadanori

フルダテサダノリ | Furudate Sadanori

Affiliation and department：
Research theme for competitive and other funds (1)：

2022 - 2024 皮膚T細胞性リンパ腫における紫外線療法の免疫学的メカニズムの解明

Papers (92)：

Taku Fujimura, Sadanori Furudate, Takeo Maekawa, Hiroshi Kato, Takamichi Ito, Shigeto Matsushita, Koji Yoshino, Akira Hashimoto, Yusuke Muto, Kentaro Ohuchi, et al. Cutaneous angiosarcoma treated with taxane-based chemoradiotherapy: A multicenter study of 90 Japanese cases. Skin Health and Disease. 2022
秋野萌子, 高橋隼也, 小林愛里, 大熊崇生, 古舘禎騎, 土山健一郎, 橋本彰, 相場節也, 森谷邦彦, 笹原洋二. 乳児の皮下に多発した神経芽腫の1例. 日本皮膚科学会雑誌. 2021. 131. 9. 2075-2075
Takami Okuma, Sadanori Furudate, Yumi Kambayashi, Akira Hashimoto, Setsuya Aiba, Taku Fujimura. Successful treatment of BRAF/MEK inhibitor-resistant advanced cutaneous melanoma with nivolumab plus ipilimumab combination therapy followed by intensity-modulated radiotherapy. The Journal of dermatology. 2021. 48. 9. 1419-1422
Taku Fujimura, Koji Yoshino, Hiroshi Kato, Yasuhiro Fujisawa, Yoshiyuki Nakamura, Yuki Yamamoto, Kayo Kunimoto, Takamichi Ito, Shigeto Matsushita, Takeo Maekawa, et al. Case series of BRAF-mutated advanced melanoma treated with encorafenib plus binimetinib combination therapy. The Journal of dermatology. 2021. 48. 3. 397-400
Yusuke Muto, Taku Fujimura, Yumi Kambayashi, Kentaro Ohuchi, Ryo Amagai, Takami Okuma, Sadanori Furudate, Akira Hashimoto, Setsuya Aiba. Dabrafenib plus trametinib combination therapy triggered onset of pustulosis palmaris et plantaris in a patient with advanced cutaneous melanoma. The Journal of dermatology. 2021. 48. 3. e135-e136-E136

ｍore...

MISC (81)：

ｍore...

Professional career (1)：

Furudate Sadanori (Tohoku University)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page